Santhera Pharmaceuticals’ License Agreement With Catalyst Pharmaceuticals

Schellenberg Wittmer advises Santhera on license for North America for Vamorolone.Santhera Pharmaceuticals (SIX: SANN) has signed an exclusive license and collaboration agreement for vamorolone in North…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here